UTHR
572.67 USD
-0.13%
Today
-0.48%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
United Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
24.75B
Avg Daily Volume
789.35K
52 Week High
607.89 USD
52 Week Low
266.98 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
Top News
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
tradingview.com
4d ago
UnitedTherapeutics
-0.48%
ServiceNow
-7.84%
US Stock Market Today S&P 500 Futures Rise On Fed Caution And Bond Jitters
finance.yahoo.com
1w ago
UnitedTherapeutics
-0.48%
Alcoa
-0.55%
ADMA.Biologics
-3.12%
Adient
-1.17%
Alaska_Air
-1.01%
Autoliv
+0.24%
Apollo
-2.49%
Butterfly_Network
-0.97%
BiogenIDEC
-2.24%
BostonSc
+0.70%
Blackstone
-1.66%
Coeur
+2.59%
Century.Aluminum
+1.02%
Carlyle_Group
-1.79%
ColgatePal
-0.52%
CrowdStrike
-4.36%
Chevron
-0.53%
Devon
+0.23%
Expedia
-1.01%
Flextronic
+2.34%
GM.Motors
+0.53%
Group1Auto
+0.01%
Hecla.Mining
+0.73%
RobinHood
-1.55%
Insmed
-3.03%
KKR&Co
-1.65%
Meta
+0.08%
NewmontM
+2.35%
Novavax
-5.52%
Occidental
+0.00%
ProPetro
+1.47%
Quanta
+0.66%
Ultragenyx
-2.44%
SoFiTech
-0.12%
Spire
-0.20%
Seagate
+0.14%
Sysco
-3.15%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM
reuters.com
1w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
